Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Charles River Laboratories to Participate in June Investor Conferences


Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at three upcoming investor conferences, including:

  • Jefferies Virtual Healthcare Conference on Tuesday, June 1st, at 10:00 a.m. ET;
  • William Blair 41st Annual Growth Stock Conference on Wednesday, June 2nd, at 11:00 a.m. ET; and
  • Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10th, at 11:20 a.m. ET

Management will present an overview of Charles River’s strategic focus and business developments.

A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after each presentation and will remain available for approximately two weeks.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210528005017/en/

Charles River Labs Intl Aktie

197,90 €
0,10 %

Positive Community-Reaktionen für Charles River Labs Intl mit mehreren Buy-Einschätzungen, keine Sell-Einschätzungen.
Die Community erwartet für Charles River Labs Intl ein Kursziel von 249 €, was eine deutliche Steigerung von über 20% gegenüber dem aktuellen Kurs von 197.9 € bedeuten könnte.
Like: 0
Teilen
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Rechtlicher Hinweis

Kommentare